lg 100268 has been researched along with cyclin d1 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Glozak, MA; Li, Y; Rogers, MB; Smith, SM | 1 |
Breyer, MD; Breyer, RM; Davis, L; Guan, YF; Zhang, YH | 1 |
Bissonnette, RP; Brown, PH; Hill, J; Hilsenbeck, SG; Kim, HT; Lamph, WW; Li, Y; Shen, Q; Xu, X; Zhang, Y | 1 |
3 other study(ies) available for lg 100268 and cyclin d1
Article | Year |
---|---|
The expression and activity of D-type cyclins in F9 embryonal carcinoma cells: modulation of growth by RXR-selective retinoids.
Topics: Alitretinoin; Animals; Antineoplastic Agents; Benzoates; Biomarkers; Carcinoma, Embryonal; Cell Adhesion; Cell Differentiation; Cell Division; Cyclin D1; Cyclin D2; Cyclin D3; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinases; Cyclins; Endoderm; Gene Expression Regulation, Neoplastic; Nicotinic Acids; Proto-Oncogene Proteins; Receptors, Retinoic Acid; Retinoid X Receptors; RNA, Messenger; Stem Cells; Tetrahydronaphthalenes; Transcription Factors; Transcription, Genetic; Tretinoin; Tumor Cells, Cultured | 1999 |
Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
Topics: Alitretinoin; Antineoplastic Agents; Apoptosis; Carcinoma, Transitional Cell; Carrier Proteins; Cell Death; Chromans; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA; DNA, Complementary; Dose-Response Relationship, Drug; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; G1 Phase; Humans; Immunoblotting; In Situ Hybridization; Ligands; Luciferases; Myelin P2 Protein; Neoplasm Proteins; Nicotinic Acids; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Ribonucleases; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation; Transfection; Tretinoin; Troglitazone; Tumor Cells, Cultured; Tumor Suppressor Proteins; Urinary Bladder Neoplasms | 1999 |
The Rexinoid LG100268 prevents the development of preinvasive and invasive estrogen receptor negative tumors in MMTV-erbB2 mice.
Topics: Animals; Anticarcinogenic Agents; Cell Line, Tumor; Cyclin D1; Female; Humans; Immunohistochemistry; Ki-67 Antigen; Mammary Tumor Virus, Mouse; Mice; Mice, Transgenic; Neoplasm Invasiveness; Neoplasm Transplantation; Nicotinic Acids; Receptor, ErbB-2; Receptors, Estrogen; Tetrahydronaphthalenes; Time Factors; Transgenes | 2007 |